Annual Drug Patent Expirations for INBRIJA
Inbrija is a drug marketed by Acorda and is included in one NDA. It is available from one supplier. There are eighteen patents protecting this drug.
This drug has one hundred and thirty-three patent family members in twenty-six countries.
The generic ingredient in INBRIJA is levodopa. One supplier is listed for this compound. Additional details are available on the levodopa profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
